Is Bioasis Technologies Inc. (BIOAF) a Buy, Sell, or Hold?
OTC : BIOAF
Bioasis Technologies Inc.
$0.0001 USD
$0 (0.0%)
- Volume
- 72.94K
- Average Volume
- 68.08K
- Market Capitalization
- $7.94K
- P/E Ratio
- -0.12
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $0.00
- Year Low
- $0.00
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $0.70
| Source | Headline |
|---|---|
|
Financial Analysis: Prelude Therapeutics (NASDAQ:PRLD) versus Bioasis Technologies (OTCMKTS:BIOAF)
Prelude Therapeutics (NASDAQ: PRLD - Get Free Report) and Bioasis Technologies (OTCMKTS:BIOAF - Get Free Report) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their institutional ownership, earnings, profitability, analyst recommendations, dividends, valuation and risk. Institutional and Insider Ownership 79.7% of Prelude Therapeutics defenseworld.net - 2026-04-27 02:24:43 |
